This month's settlement of the federal racketeering case against Tenet's Alvarado Medical Center in San Diego appears to open the door for the company to leave its troubles behind. That fact, combined with a blue dot special share price around $7, has made the company one of the most closely watched on Wall Street over the past month. But it is also the subject of controversy. Can a company that has had as many problems as Tenet has had ever be considered safely out of the woods? The Wall Street Journal takes a detailed look at the arguments of the two camps.
- read this Wall Street Journal article (sub. req.)
PLUS: On Thursday, Tenet named a new chief financial officer, appointing Raytheon's "Biggs' Porter to the post. But not everybody thinks importing a CFO from a company with a history of accounting problems of its own is such a hot idea. Article